Published: 2021-03-20 16:15
Last Updated: 2023-06-07 11:36
American doctors and scientists promised the world a new drug that will reduce hospital admissions by 90 percent and therefore reduce overall deaths caused by COVID-19 as well.
Saturday, the head of the Respiratory Research Department at the Blessing Health System in the U.S. Humam Farrah told Roya this drug is made from 'Monoclonal antibodies' that are injected into the vein of high risk coronavirus patients, such as the elderly, people with chronic diseases and those suffering from obesity.
Patients can be given the drug as long as the viral infection has not reached the lungs and immediately after testing positive for COVID-19.
The research team has already started giving it to some coronavirus patients, whose health condition has worsened and were admitted to the Intensive Care Unit but there were no positive results.
He added that the drug prevents severe symptoms in the respiratory system, lung infections and COVID-19 deaths in general.
Farrah pointed out that the injection of these antibodies as well as the COVID-19 vaccines are what led to the significant decrease in the number of cases and deaths in America.
He said that the second stage of research is now complete and researchers have started working on stage three. He noted that the US Food and Drug Administration (FDA) has already given this drug emergency approval for manufacturing and distribution, because so far it has proven to be effective and safe.
He pointed out that the US government owns the drug and provides all funds for research, manufacturing and distribution. He believes that it will soon be made available to other countries.
This drug is administered intravenously but research is ongoing to determine whether it can also be given intramuscularly or orally.
Regarding COVID-19 vaccines, Farrah said all vaccines are good and safe, but in his opinion, the Pfizer-BioNTech and Moderna vaccines are the most effective.
He stressed that the COVID-19 situation in America is improving and that, if the vaccination program continues to vaccinate approximately 2.5 million people per day, America will start gradually returning to normalcy in June or July.